This announcement was almost a year ago. San Ma
Post# of 22454
(Total Views: 331)
Posted On: 09/08/2022 7:49:23 AM
This announcement was almost a year ago.
San Marcos, TX, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Quantum Materials Corp (QMC) announces Vac-Check™, a new tool to combat the global threat of fake vaccines. Building on experience in nanomaterials, Quantum Material Corp’s scientists created a patent-pending, lateral flow assay powered by QMC’s proprietary quantum dot technology to test vaccines at the point of use.
Analysts forecast the vaccine market to grow to $100 billion by 2027. Counterfeit vaccines are a growing problem in the global trade of illegal and fake pharmaceuticals. Unfortunately, counterfeit vaccines can disrupt the supply chain, can be hard to distinguish, and may result in serious consequences.
“The Covid pandemic supercharged the problem of fake vaccines. Vac-Check™ enables a vaccine tech or administrator to sample and test the contents of a vaccine vial at any point in the supply chain, but most importantly, at the point of use.” said Stephen Squires, CEO of Quantum Materials Corporation. “Vac-Check™ is revolutionary, has no power requirements, can be shipped anywhere, and can render a test result in 20 minutes or less. Vac-Check™ is a small, single use assay that offers a new level of confidence for those managing vaccination programs globally.”
Vac-Check™ is an assay platform designed to work with many vaccine types, in addition to SARS-CoV-2. Furthermore, the Vac-Check™ platform streamlines logistics and field deployment activities with vaccine manufacturers. Quantum Materials Corp welcomes the opportunity to work with vaccine manufacturers to rapidly make this life saving technology widely available.
Vac-Check™ is available for immediate evaluation by vaccine manufacturers.
Questions:
Does Vac-Check have to have FDA approval?
If so, has it been approved?
Has Vac-Check been copyright or patent applied for?
Have any manufactures shown interest?
Is this something Tony Podesta could be working on?
I would like to think all of the answers are "yes".
All or part of these questions could be answered in a shareholder update that I hope is coming soon.
QTMM has so many irons in the fire. I think Steve must want all ducks in a row before making any form of announcement. Surely, something will happen with so many possibilities. For shareholders, patience is key. No other choice.
San Marcos, TX, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Quantum Materials Corp (QMC) announces Vac-Check™, a new tool to combat the global threat of fake vaccines. Building on experience in nanomaterials, Quantum Material Corp’s scientists created a patent-pending, lateral flow assay powered by QMC’s proprietary quantum dot technology to test vaccines at the point of use.
Analysts forecast the vaccine market to grow to $100 billion by 2027. Counterfeit vaccines are a growing problem in the global trade of illegal and fake pharmaceuticals. Unfortunately, counterfeit vaccines can disrupt the supply chain, can be hard to distinguish, and may result in serious consequences.
“The Covid pandemic supercharged the problem of fake vaccines. Vac-Check™ enables a vaccine tech or administrator to sample and test the contents of a vaccine vial at any point in the supply chain, but most importantly, at the point of use.” said Stephen Squires, CEO of Quantum Materials Corporation. “Vac-Check™ is revolutionary, has no power requirements, can be shipped anywhere, and can render a test result in 20 minutes or less. Vac-Check™ is a small, single use assay that offers a new level of confidence for those managing vaccination programs globally.”
Vac-Check™ is an assay platform designed to work with many vaccine types, in addition to SARS-CoV-2. Furthermore, the Vac-Check™ platform streamlines logistics and field deployment activities with vaccine manufacturers. Quantum Materials Corp welcomes the opportunity to work with vaccine manufacturers to rapidly make this life saving technology widely available.
Vac-Check™ is available for immediate evaluation by vaccine manufacturers.
Questions:
Does Vac-Check have to have FDA approval?
If so, has it been approved?
Has Vac-Check been copyright or patent applied for?
Have any manufactures shown interest?
Is this something Tony Podesta could be working on?
I would like to think all of the answers are "yes".
All or part of these questions could be answered in a shareholder update that I hope is coming soon.
QTMM has so many irons in the fire. I think Steve must want all ducks in a row before making any form of announcement. Surely, something will happen with so many possibilities. For shareholders, patience is key. No other choice.
(0)
(0)Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼